Orthofix Medical Inc (OFIX) Actualités

Orthofix to Participate in the 37th Annual Roth Conference

Monday, March 17, 2025 at 8:00 am Pacific Time Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced...

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance

Record Results Reflect Strong Execution as Company Focuses on Most Profitable Growth Opportunities in Spine, Orthopedics and Bone Growth...

Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 9:00 am Pacific Time Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results

Company to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ET Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership